{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.391","meta":{"versionId":"4","lastUpdated":"2017-12-01T01:00:04.000-05:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Patient reasons no adjuvant hormonal therapy</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://www.ama-assn.org/go/cpt</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>2P</td>\n              <td>Performance Measure Exclusion Modifier due to Patient Reasons</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>4164F</td>\n              <td>Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.391","version":"20171201","name":"Patient reasons no adjuvant hormonal therapy","status":"active","date":"2017-12-01T01:00:04-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","concept":[{"code":"2P","display":"Performance Measure Exclusion Modifier due to Patient Reasons"},{"code":"4164F","display":"Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)"}]}]}}